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Abstract
The activity of the serine protease in the German cockroach allergen is important to the development of allergic disease.
The protease-activated receptor (PAR)-2, which is expressed in numerous cell types in lung tissue, is known to mediate the
cellular events caused by inhaled serine protease. Alveolar macrophages express PAR-2 and produce considerable amounts
of tumor necrosis factor (TNF)-a. We determined whether the serine protease in German cockroach extract (GCE) enhances
TNF-a production by alveolar macrophages through the PAR-2 pathway and whether the TNF-a production affects GCE-
induced pulmonary inflammation. Effects of GCE on alveolar macrophages and TNF-a production were evaluated using in
vitro MH-S and RAW264.6 cells and in vivo GCE-induced asthma models of BALB/c mice. GCE contained a large amount of
serine protease. In the MH-S and RAW264.7 cells, GCE activated PAR-2 and thereby produced TNF-a. In the GCE-induced
asthma model, intranasal administration of GCE increased airway hyperresponsiveness (AHR), inflammatory cell infiltration,
productions of serum immunoglobulin E, interleukin (IL)-5, IL-13 and TNF-a production in alveolar macrophages. Blockade
of serine proteases prevented the development of GCE induced allergic pathologies. TNF-a blockade also prevented the
development of such asthma-like lesions. Depletion of alveolar macrophages reduced AHR and intracellular TNF-a level in
pulmonary cell populations in the GCE-induced asthma model. These results suggest that serine protease from GCE affects
asthma through an alveolar macrophage and TNF-a dependent manner, reflecting the close relation of innate and adaptive
immune response in allergic asthma model.
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Introduction
German cockroaches are a well-known causative allergen for
allergic asthma [1]. It contains several major allergens and
proteases. Classically, allergens induce immune responses that lead
to Th2 lymphocyte differentiation, production of IgE, and mast
cell activation; however, prolonged administration of allergen may
induce regulatory T cells and tolerance to the allergens [2].
Recently, another type of allergens were classified as type II
allergens, and these allergens bypass normal tolerogenic mecha-
nisms and directly induce allergic diseases by sensitization of local
routes [3,4]. One example of such type II allergens includes the
active proteases derived from cockroach, house dust mite, and
fungal extracts.
German cockroach extract (GCE) was reported to contain
active serine proteases [5,6,7]. Serine protease affects the
development of inflammation and allergic immune responses
through specific receptor systems, such as the protease-activated
receptor (PAR)-2 in a variety of cell types [4]. PAR-2, a member of
the G protein-coupled receptor family [8], is activated by various
serine proteases such as mast cell tryptase [9], trypsin-like enzymes
[10], and certain allergens from house dust mites [11] or
cockroaches [8,12]. Serine proteases stimulate the N-terminal
exodomain of the receptor and cleave the receptor at this site [13].
Alteration of PAR-2 results in coupling and activation of G
proteins, triggers a cascade of signaling events, and thereby leads
to intracellular Ca2+ influx [14] and tumor necrosis factor (TNF)
production. These events contribute to the development of
eosinophilic inflammation and airway hyperresponsiveness
(AHR) in asthma [4]. Others, however, have reported that
PAR-2 may be protective against bronchoconstriction or AHR
[15]. Thus, the role of PAR-2 in asthma remains controversial.
PAR-2-expressing cells, such as alveolar macrophages [13],
epithelial cells, mast cells, and fibroblasts are located throughout
the airways and encounter inhaled allergens or particles that
contain serine protease activity. Alveolar macrophages are able to
produce large amounts of TNF-a [4,16]. Recent studies indicated
that depletion of alveolar macrophages [17] or blockade of TNF-a
[18] prevents AHR and progressive inflammatory injuries in an
ovalbumin-induced asthma model. TNF-a blockade also amelio-
rates AHR, impairment of lung function, and quality of life in
patients with severe asthma [19,20]. These findings suggest that
TNF-a expression by alveolar macrophages may play a key role in
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allergic inflammation, especially when induced by indoor allergens
such as house dust mites, fungus or cockroaches.
In this study, we investigated whether alveolar macrophages are
stimulated by GCE through PAR-2 and whether production of
TNF-a by alveolar macrophages plays a key role in the




Female BALB/c Cr Slc mice (6-weeks) were purchased from
Japan-SLC (Hamamatsu, Japan). This study was carried out in
strict accordance with the recommendations in the Guide for the
Care and Use of Laboratory Animals of the Institute of Laboratory
Animal Resources Commission on Life Sciences National
Research Council, USA. The protocol was approved by Institu-
tional Animal Care and Use Committee (08–183) in Yonsei
University College of Medicine (Seoul, Korea), which has been
fully accredited by the Association for Assessment and Accredi-
tation of Laboratory Animal Care, International.
Mice exposed intranasally to GCE (100 mg/mouse) 3 times per
week for 2 or 4 weeks (short- and long-term GCE exposure
models, respectively).
GCE preparation
GCE was prepared as previously described [7]. Fifty grams of
frozen German cockroaches were homogenized in liquid nitrogen
and defatted in 200 mL of ethyl ether and 200 mL of ethyl
acetate. Extractions were preformed with slow stirring at 4uC
overnight in PBS containing 6 mmol/L 2-mercaptoethanol and
1 mg/mL 1-phenyl-3-(2-thiazolyl)-2-thiourea to prevent melani-
zation. The extract was then centrifuged at 10,0006g for
30 minutes at 4uC, and the supernatant was finally filtered
through 0.2-mm filters. The endotoxin from the supernatant was
removed by the Detoxi-GelTM Endotoxin Removing Gel (Pierce
Biotechnology, Rockford, IL). The endotoxin from the GCE was
removed and measured to be below 0.01 EU/mL by the
chromogenic Limulus Amebocyte Lysate test (Lonza, Walkersville,
MD). The GCE contained 0.11 U/mg Bla g1.
Protease activity measurement
Protease activity of GCE was measured using a Protease
Fluorescent Detection Kit (Sigma-Aldrich, St. Louis, MO)
according to the supplier’s recommendations [21]. A fluorescein
isothiocyanate (FITC)-casein and GCE were prepared and the
fluorescence intensity was recorded by Luminescence Spectrom-
eter (Perkin-Elmer, Oak Brook, IL).
Cell culture
MH-S and RAW264.7 cells (ATCC, Manassas, VA) were
stimulated with GCE, ENMD-1068 (Enzo Life Sciences, Farm-
ingdale, NY), aprotinin, or polymixin B (PMB; Sigma-Aldrich).
The cells were cultured in Dulbecco’s modified Eagle medium
supplemented with 10% fetal bovine serum and 100 U/mL
penicillin-streptomycin.
Liposome-encapsulated Cl2MDP
Liposomes encapsulated with dichloromethylenediphosphonic
acid disodium salt (Cl2MDP; Sigma-Aldrich) were prepared as
previously described [22]. Briefly, 86 mg phosphatidylcholine and
8 mg cholesterol were dissolved in 10 mL chloroform or 4 mL
PBS, and a lipid film was manufactured by low vacuum rotary
evaporation. The suspension, which was dissolved in either 10 mL
Cl2MDP or 4 mL PBS, was kept at room temperature for 2 hours
and then sonicated for 5 minutes. The suspensions were then
centrifuged at 100,0006g for 30 minutes to remove free Cl2MDP.
The Cl2MDP-containing liposomes and the control liposomes
were resuspended in 2 mL PBS.
AHR measurement
AHR was measured as previously described [23]. Mice were
anesthetized (pentobarbital sodium, intraperitoneally), ventilated
(flexiVent 5.1H; SCIREQ, Montreal, Canada) and challenged with a
saline aerosol followed by increasing concentrations of methacho-
line (MCh; Sigma-Aldrich). Aerosols were generated with an
ultrasonic nebulizer (Omron Healthcare, Kyoto, Japan) and
delivered to the inspiratory line of the flexiVent using a bias flow
of medical air.
BAL fluid
Bronchoalveolar lavage (BAL) fluid was obtained as previously
described [23]. To collect BAL fluid, the lungs were lavaged with
1 mL Hank’s balanced salt solution (HBSS) via the tracheostomy
tube. Total cell numbers were counted with a hemocytometer.
After the procedure, BAL fluid was centrifuged at 1,5006g for 3
minutes at 4uC, and then smears of BAL cells were prepared by
cytocentrifugation (Cytospin3, Thermo, Billerica, MA) at
1,000 rpm for 3 minutes. BAL cells were stained with Hemacolor
Staining Kit (Merck, Darmstadt, Germany) counted, and classified
as neutrophils, eosinophils, lymphocytes, or macrophages.
Lung homogenate
For assessment of cytokine levels, lung tissues were homoge-
nized in 20 mL/g tissue protein extraction reagent (Thermo
Fisher Scientific Inc., Rockford, IL) using a tissue homogenizer
(Biospec Products, Bartlesville, OK). Homogenates were incubated
at 4uC for 30 min and then centrifuged at 1,0006g for 10 min.
Supernatants were collected, passed through a 0.45-micron filter
(Gelman Sciences, Ann Arbor, MI), and then stored at 270uC for
assessment of cytokine levels.
Immunocytohistochemistry
Immunofluorescence staining of PAR-2 and TNF-a in Raw
264.7 cells and lung tissues was examined by confocal laser
scanning microscopy (LSM700, Carl Zeiss, Jena, Germany).
Cytospin-fixed RAW 264.7 cells or formalin-fixed, paraffin-
embedded lung tissues were stained with FITC anti-mouse
PAR-2 (SAM11, Santa Cruz Biotechnology, Santa Cruz, CA),
phycoerythrin (PE) anti-mouse CD11b, and allophycocyanin
(APC) anti-mouse TNF-a (BD PharmingenTM, San Jose, CA) at
4uC for 30 minutes. After staining, the samples were washed and
observed under confocal laser scanning microscopy with excitation
Figure 1. Serine protease of GCE activates PAR-2. (a) Standard curve of trypsin at concentrations ranging from 0.16 to 20 mg/mL. (b) Serine
protease activities on FITC-casein. * indicates statistical significance compared with ‘‘GCE’’ (n = 3, p,0.05). (c) PAR-2 internalization following
activation with GCE and/or aprotinin in MH-S cells. Internalization of the PAR-2 is visualized by confocal imaging of intracellular staining. Intracellular
expressions of (d) PAR-2 and (f) TNF-a in MH-S cells incubated with GCE or GCE+ENMD. (e) and (g) are relative MFI ration in ‘‘d’’ and ‘‘f’’ panels,
respectively. * indicates statistical significance between ‘‘Control’’ and ‘‘GCE’’ (n = 3, p,0.05), # indicates statistical significance between ‘‘GCE’’ and
‘‘GCE+ENMD’’ (n = 3, p,0.05). All data are representative of three independent experiments. ENMD, ENMD-1068.
doi:10.1371/journal.pone.0047971.g001
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Figure 2. GCE induces TNF-a production in macrophages. (a) TNF-a production in MH-S cells incubated with GCE, GCE+PMB, or
GCE+aprotinin. (b) Relative MFI ratio in ‘‘a’’ panel. (c) TNF-a secretion in the culture supernatant of ‘‘a’’ panel. * indicates statistical significance
between ‘‘Control’’ and ‘‘GCE’’ (n = 3, p,0.05). # indicates statistical significance between ‘‘GCE’’ and ‘‘GCE+Aprotinin’’ (n = 3, p,0.05). (d) Scheme for
short-term GCE exposure model. Kinetics of intracellular (e) PAR-2 and (g) TNF-a expression from alveolar macrophages in the BAL fluid of the short-
term GCE exposure model. (f) Relative MFI ratio in ‘‘e’’ panel. (h) Relative MFI ratio in ‘‘g’’ panel. * indicates statistical significance to ‘‘D0’’ (n = 5,
p,0.05). # indicates statistical significance between ‘‘D12’’ and ‘‘a-TNF’’ (n = 5, p,0.05). All data are representative of three independent experiments.
doi:10.1371/journal.pone.0047971.g002
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Figure 3. GCE promotes pulmonary inflammation through the TNF-a pathway. (a) Scheme for TNF-a neutralization of GCE-induced asthma
model. a-TNF, anti-TNF-a mAb; goat, goat IgG. (b) AHR and (c) BAL cell count. (d) TNF-a-producing macrophage population in the lung tissue. (e)
Quantitative analysis of CD11b+TNF-a+ cell population from ‘‘d’’ panel. (f) TNF-a levels in lung homogenates. * indicates statistical significance
between ‘‘Sham’’ and ‘‘GCE’’ (n = 5, p,0.05). # indicates statistical significance between ‘‘GCE’’ and ‘‘a-TNF’’ (n = 5, p,0.05). All data are representative
of three independent experiments. RL, pulmonary resistance; Mac, macrophage; Lym, lymphocyte; Eos, eosinophil; Neu, neutrophil.
doi:10.1371/journal.pone.0047971.g003
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wavelengths of 493, 565, and 645 nm and emission wavelengths of
525, 575, and 660 nm, respectively.
Intracellular cytokine staining
Intracellular cytokine staining was performed using a Cytofix/
Cytoperm kit (BD Biosciences, San Diego, CA) according to the
supplier’s recommendations. The cells were stained with PE/Cy7-
anti-mouse CD4, PE-anti-mouse CD11b, PerCP/Cy5.5-anti-
mouse CD11c and PE/Cy7-anti-mouse F4/80, permeabilized,
and stained intracellularly with FITC-anti-mouse IFN-c, PE-anti-
mouse IL-5, APC-anti mouse IL-17, APC-anti-mouse TNF-a (BD
Pharmingen), FITC- and PE-anti-mouse PAR-2 (Santa-Cruz
Biotechnology).
Flow cytometric analysis
We performed multicolor-flow cytometric analysis (LSRII; BD
Biosciences). The data were analyzed using FACSDiva (BD
Biosciences) or FlowJo ver.7.6.2 (Three Star, Ashland, OR) and
expressed as a percentage value or mean fluorescence intensity
(MFI). The relative-MFI ratio was calculated relative to the
control group.
ELISA
TNF-a, IFN-c, IL-5 and IL-13 were detected by enzyme-linked
immunosorbent assay (ELISA) with a DuoSetH ELISA (R&D
Systems, Minneapolis, MN). Immunoglobulin (Ig)E was detected
with an IgE ELISA set (BD Biosciences).
Pulmonary pathology analysis
Periodic Acid-Schiff (PAS) and Masson’s Trichrome staining
were performed in the formalin-fixed/paraffin-embedded lung
tissues. Tissue sections were examined with an Olympus BX40
microscope in conjunction with an Olympus U-TV0.63XC digital
camera (Olympus Corp., Melvile, NY). Images were acquired
using DP Controller and Manager software (Olympus Corp.).
PAS+cells per millimeter of bronchial basement membrane
(mmBM) and Trichrome+pixels per total area (%) were measured
by MetaMorph 4.6 (Universal Imaging, Downingtown, PA).
Statistical analysis
The data are expressed as mean6standard error. Statistical
analyses were measured using SPSS ver.12.0 (Chicago, IL). Paired
groups were compared using the Student’s t-test, and all
differences were considered significant at p,0.05.
Results
Serine protease activity of GCE activates PAR-2 in
macrophages
German cockroaches exhibit protease activity that includes
serine- and cysteine-degrading enzymes. We measured the
protease activity in GCE on a FITC-casein substrate. Compared
to the typical standard curve of trypsin from 0.16 mg/mL to 20
mg/mL on the FITC-casein substrate, one milligram of the GCE
contained protease activity that was equivalent to 21.87 mg/mL
trypsin (Figure 1A and 1B). To identify the specific protease
activity in GCE, GCE was incubated with several protease
inhibitors that inhibited serine or cysteine protease classes. When
GCE was incubated with aprotinin-a serine protease inhibitor, E-
64-a cysteine protease inhibitor, phenylmethanesulfonyl fluoride
(PMSF)-a serine/cysteine protease inhibitor, and soybean trypsin
inhibitor (STI)-a trypsin inhibitor, each protease activities were
decreased. In addition, one of these inhibitors, aprotinin, markedly
reduced protease activity in the GCE (Figure 1B).
To determine PAR-2 immunolocalization following GCE
stimulation in the mouse macrophages, alveolar macrophage cell-
lines (MH-S cells) and peritoneal macrophage cell-lines (RAW264.7
cells) were incubated with eitherGCE or a combination ofGCE and
aprotinin. GCE stimulation led to internalization of the PAR-2 in
theMH-S cells, while the cells incubatedwith a combination ofGCE
and aprotinin revealed similar patterns of control, as visualized by
confocal imaging of intracellular staining (Figure 1C) and cell
surface staining samples (Figure S1). In the RAW264.7 cells, PAR-2
expression of the cell surface decreased following GCE stimulation,
but the cells incubated with a combination of GCE and aprotinin
revealed similar to the control (Figure S2)
To confirm a specific interaction between the GCE and the
PAR-2, MH-S cells were incubated with an ENMD-1068, a novel
selective PAR-2 antagonist [24,25,26], and then stimulated with
GCE. The intracellular expression of PAR-2 and TNF-a was
markedly inhibited by ENMD-1068 (Figure 1D–G).
GCE induces TNF-a production in macrophages
To examine whether PAR-2 activation by serine proteases
within GCE induces inflammation via macrophages, we studied
TNF-a production and secretion in the MH-S and RAW264.7
cells. Intracellular TNF-a levels were significantly increased in
GCE- stimulated MH-S cells, but these levels were not increased
when GCE protease activity was inhibited by aprotinin. In
GCE+PMB-stimulated condition, the endotoxin level less than 0.1
EU/mL in GCE had no effect in GCE-stimulated cells (Figure 2A
and 2B). These results showed that serine protease but not
endotoxin in GCE is critical for TNF-a production. The culture
supernatants from cells grown under each condition revealed
similar patterns of TNF-a production (Figure 2C). The results of
RAW264.7 cells revealed similar to the MH-S cells (Figure S3).
To identify the kinetics of PAR-2 and TNF-a expression during
GCE stimulation process, GCE was administered intranasally to
BALB/c mice 3 times per week for 2 weeks (short-term GCE
exposure model; Figure 2D). Intracellular PAR-2 and TNF-a
levels of alveolar macrophages (CD11c+ and F4/80+ cells) were
increased continuously for up to 2 weeks (Figure 2E–2G).
According to the immunohistochemistric analysis, TNF-a
accumulation of macrophages were increased in the lung tissues of
long-term GCE exposure model (3 times per week for 4 weeks;
Figure S4).
GCE promotes pulmonary inflammation through the
release of TNF-a
To determine whether GCE promotes allergic asthma-like
symptoms, we used a long-term GCE exposure model (Figure 3A).
In an AHR assay, mice that received GCE developed pulmonary
resistance based on the requirement for increasing doses of MCh
inhalation (Figure 3B). The mice receiving GCE exhibited
Figure 4. GCE promotes allergic phenotype through the TNF-a pathway. Lung homogenates were harvested and used for measuring (a) IL-
5, (b) IL-13 and (c) IFN-c. (d) The level of serum IgE in the blood. Lung tissues were stained with (e) PAS and (f) Masson’s Trichrome. (g) PAS-positive
cells in peri-bronchial regions and (h) total collagen deposition in the lung tissue were quantitatively calculated. * indicates statistical significance
between ‘‘Sham’’ and ‘‘GCE’’ (n = 5, p,0.05). # indicates statistical significance between ‘‘GCE’’ and ‘‘a-TNF’’ (n = 5, p,0.05). All data are representative
of three independent experiments.
doi:10.1371/journal.pone.0047971.g004
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Figure 5. Serine protease in GCE develops pulmonary inflammation, alveolar macrophage infiltration and TNF-a expression. (a)
Scheme for the inhibition of GCE protease activity of GCE-induced asthma model. (b) AHR and (c) BAL cell count. (d) Alveolar macrophage, interstitial
macrophage, and dendritic cell population in the lung tissue. (e) Quantitative analysis of alveolar macrophage from ‘‘d’’ panel. (f) Intracellular
The Role of Macrophage in Cockroach-Induced Asthma
PLOS ONE | www.plosone.org 8 October 2012 | Volume 7 | Issue 10 | e47971
inflammatory cell infiltration in the BAL fluid, and the majority of
the cells in the BAL fluid were macrophages, lymphocytes, and
neutrophils (Figure 3C). Intracellular TNF-a production and
secretion of the macrophages were increased in the long-term
GCE exposure model (Figure 3D–3F).
To confirm the helper T cell differentiation during GCE-
stimulation, intracellular and secreted levels of different cytokines
expressions of TNF-a in the alveolar macrophages of the GCE-induced asthma experiment. (g) Relative MFI ratio in ‘‘f’’ panel. * indicates statistical
significance between ‘‘Sham’’ and ‘‘GCE’’ (n = 5, p,0.05). # indicates statistical significance between ‘‘GCE’’ and ‘‘GCE+Aprotinin’’ (n = 5, p,0.05). All
data are representative of three independent experiments. AMs, alveolar macrophages; IMs, interstitial macrophages; DCs, dendritic cells.
doi:10.1371/journal.pone.0047971.g005
Figure 6. Alveolar macrophages are the major source of TNF-a in the GCE-induced asthma model. (a) Scheme for the alveolar
macrophage depletion of GCE-induced asthma model. Cl2MDP, Cl2MDP-containing liposomes; Liposome, control liposomes. (b) Macrophages from
BAL fluid and (c) AHR in alveolar macrophage-depleted animals. (d) Intracellular TNF-a production in lung tissue. (e) Relative MFI ratio in ‘‘d’’ panel. *
indicates statistical significance between ‘‘Liposome/sham’’ and ‘‘Liposome/GCE’’ (n = 5, p,0.05). # indicates statistical significance between
‘‘Liposome/GCE’’ and ‘‘Cl2MDP/GCE’’ (n = 5, p,0.05). All data are representative of three independent experiments. Liposome/sham, control liposome-
treated group; Liposome/GCE, control liposome-treated GCE-treated group; Cl2MDP/sham, Cl2MDP-containing liposome-treated sham group; Cl2MDP/
GCE, Cl2MDP-containing liposome-treated GCE-treated group.
doi:10.1371/journal.pone.0047971.g006
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in CD4+ T cells were measured. The intracellular levels of IFN-c,
IL-5 and IL-17 were increased in the CD4+ T cells of the long-
term GCE exposure mice (Figure S5A and S5B).IFN-c, IL-5, IL-
10, IL-13 and IL-17 production in lung, and serum IgE levels were
also increased in this model (Figure 4A–4D; Figure S5C).
Histologically, goblet cell hyperplasia and collagen deposition in
the peri-bronchiolar area were exacerbated in the long-term GCE
exposure model as compared to controls (Figure 4E–4H).
To confirm the role of TNF-a in the long-term GCE exposure
model, we blocked TNF-a in these animals. We intravenously
injected goat anti-mouse TNF-a polyclonal antibody (10 mg/
mouse, R&D Systems) or goat IgG (10 mg/mouse, R&D Systems)
into the animals intravenously 12 hours before the first, 7th, 14th,
and 21st administrations of GCE (Figure 3A). The development of
AHR and airway inflammation following GCE administration was
attenuated by the systemic neutralization of TNF-a in these mice
(Figure 3B and 3C). TNF-a blockade reduced intracellular TNF-a
production in the macrophages as well as TNF-a secretion from
the lung tissues of the long-term GCE exposure mice (Figure 3D–
3F). TNF-a blockade also decreased Th2 cytokine production,
serum IgE levels, goblet cell hyperplasia, and peri-bronchial
fibrosis in the long-term GCE exposure model (Figure 4).
To confirm the effect of TNF-a blockade, as a therapeutic
agent, we blocked TNF-a just before the last challenge in a short-
term GCE exposure model. In this model, both AHR and
inflammatory cell infiltration in the BAL fluid also improved
(Figure S6), and kinetically increased of PAR-2 and TNF-a levels
of alveolar macrophages were diminished in the TNF-a blockade
group (Figure 2E–2G).
Serine protease activity of GCE develops allergic
pulmonary inflammation.
We identified whether the serine protease activity of GCE has a
critical role in the pulmonary allergic inflammation in the short-
term GCE exposure model. We incubated GCE with aprotinin
(100 mg) and administered the GCE+aprotinin intranasally to the
mice 3 times per week for 2 weeks (Figure 5A). When the serine
protease activity of GCE was inhibited by aprotinin, AHR
(Figure 5B) and airway inflammation (Figure 5C) was attenuated.
The inhibition of GCE protease activity reduced the infiltrations of
alveolar macrophages (CD11c+ and F4/80+ cells; Figure 5D and
5E) and the intracellular TNF-a production of the alveolar
macrophages (TNF-a+, CD11c+ and F4/80+ cells; Figure 5F and
5G), whereas it did not affect the infiltration of interstitial
macrophages (CD11c2 and F4/80+ cells) nor dendritic cells
(CD11c+ and F4/802 cells) in the short-term GCE exposure
model (Figure 5D and Figure S7).
Activated alveolar macrophages and their TNF-a
production promote GCE-induced pulmonary
inflammation
According to our in vitro and in vivo studies, we demonstrated
that serine protease activity in the GCE stimulated macrophages,
which are the major source of TNF-a production. To examine the
function of alveolar macrophages in the short-term GCE exposure
models, we intranasally treated mice with Cl2MDP-containing
liposomes (50 mL/mouse) or control liposomes (50 mL/mouse)
intranasally 12 hours before the first administration of GCE and
then selectively eliminated alveolar macrophages (Figure 6A). The
number of macrophages in the BAL fluid and the AHR induced
by the GCE treatment were significantly reduced in the alveolar
macrophage-depleted mice compared to the non-depleted animals
(Figure 6B and 6C). Intracellular TNF-a levels in the lung cells of
short-term GCE exposure mice were significantly decreased by
depletion of the alveolar macrophages (Figure 6D and 6E).
Discussion
In this study, we showed that GCE contains strong serine
protease activity and that the serine proteases activated and
internalized PAR-2 in GCE-stimulated MH-S and RAW264.7
cells. Upon binding of the serine protease to PAR-2 in a cell, an N-
terminal bond at Arg34-Ser35 of PAR-2 is cleaved, and the newly
exposed N-terminal sequence activates the receptor as a ‘‘tethered
ligand’’. This PAR-2 activation results in G protein-mediated
intracellular signaling and triggers release of inflammatory
cytokines in the airway [27]. The receptor is then internalized
for recycling or lysosomal degradation [28]. PAR-2 can also be
activated by tryptase from mast cells, and thus, the presence of
protease activity may not be essential for the other inhalant
allergens. In fact, cat dander and dog dander allergens are well-
known inhalant allergens for asthma or allergic rhinitis, but these
allergens do not contain protease activities [29].
Asthma is the common chronic inflammatory disease of the
airway and one of the causes of asthma, indoor allergen is
associated with asthma development [30]. Mouse models of
asthma induced by allergen exposure have been developed and
characterized by the reproducible AHR, inflammation and
remodeling. Both short- and long-term exposure of allergens have
caused the development of allergic asthma [31]. In our study, both
short- and long-term exposure to GCE without additional
adjuvants induced allergic asthma-like lesions in BALB/c mice,
but the types of pulmonary inflammation between these groups
were different. In long-term GCE exposure mice, neutrophils
rather than eosinophils were more infiltrated in the BAL fluid, and
IL-17-produced helper T cells were increased in the lung tissue.
Previously, other groups have shown that longer exposure to
allergens can lead to tolerance [32,33,34] and Th17-mediated
airway remodeling [35]. Our results partially suggest that a long-
term exposure to GCE has the possibility to induce prominent IL-
10 and IL-17 production. Indeed, GCE exposure caused AHR,
Th2 cytokine production, and serum IgE secretion. Histologically,
goblet cell hyperplasia and fibrosis in the peri-bronchiolar area
were exacerbated in the GCE-induced asthma model. These
results show that the active serine protease of the GCE may boost
allergen-mediated immune responses without the aid of adjuvant,
suggesting that the protease activities in cockroaches may actually
have adjuvant effects to sensitize the animals to cockroach
allergens [36]. These features are also found in house dust mite
allergen-induced asthma models, as these allergens also possess
strong serine and cysteine protease activities [37], and other
substances acting as adjuvants [38]. Recently, some investigators
have reported that cockroach has cysteine protease [39,40] and it
can also activate PAR-2 pathway [41,42]. Protease inhibition
assay in our results also revealed that GCE sufficiently contained
serine protease as well as cysteine protease. However, it has also
been reported that cysteine protease in cockroach does not have a
sufficient role in the induction of allergic airway inflammation [43]
and pro-inflammatory effect on airway epithelial cells to cockroach
[44].
Macrophages are a major cell type in lung tissue, and most of
these cells exist in the pulmonary alveolus [45]. It involve in both
the innate and adaptive immune responses and may be one of the
major sources of IL-13 in asthma in mouse models [46].
Furthermore, activation of alveolar macrophages by Th2 cytokines
results in stimulation of the allergic immune responses, airway
inflammation [47], and pulmonary fibrosis [48].
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Recently, Day and coworkers (2010) had investigated the
relationship between serine protease, PAR-2, alveolar macrophag-
es and TNF-a in German cockroach frass inhaled mice [49]. They
also presented that the proteases in frass could induce the innate
immune response in mice via activation of PAR-2 [43]. In this
study, we hypothesized that PAR-2 activation of the alveolar
macrophages and production of pro-inflammatory components,
such as TNF-a, play a critical role in the GCE-induced asthma
model. In addition to macrophages, PAR-2 is also expressed by
epithelium, myocytes, neutrophils and T lymphocytes, and these
type of cells may play important roles in sensitization, initiation
and persistency of allergic inflammation [3,4,7,8,50]. In this study,
we showed that GCE induced considerable amount of TNF-a
production in alveolar macrophages via PAR-2 pathway in vitro
cross-sectional and in vivo kinetic study; however, other investiga-
tors showed that PAR-2 may play a protective role against
bronchoconstriction or AHR in rat, mouse, and guinea pig by the
release of a cyclooxygenase product from the epithelium [15]. So it
is still controversial that PAR-2 expression mediates either
proinflammatory or anti-inflammatory activities in inflammatory
lung disorders [51].
TNF is a pleiotrophic cytokine for the innate immune response
and implicated in the mechanisms of several inflammatory
diseases, such as chronic asthma, inflammatory bowel disease,
and rheumatoid arthritis, and it is produced mainly by activated
macrophages in various tissues [18]. This cytokine is a chemoat-
tractant for eosinophils and neutrophils, increases expression of
adhesion molecules in epithelium and endothelium, activates T
lymphocytes, and enhances the contractility and proliferation of
airway smooth muscle cells [18]. PAR-2 induced TNF-a may
activate dendritic cells and enhance allergen uptake by the cells
and ultimately promote allergen sensitization instead of tolerance
[4]. This notion is supported by the findings that PAR-2 knock-out
mouse has developmental defects in dendritic cells [52]. In many
studies, anti-TNF-a therapy has been regarded as an attractive
strategy for the management of asthma [18,20]. In support of this
idea, we found that neutralization of TNF-a attenuated produc-
tion of Th1 and Th2 cytokines, specific IgE, TNF-a and PAR-2
expression by alveolar macrophages, and airway remodeling, and
these features can be seen even it was administered after
establishment of GCE induced allergic inflammation, suggesting
that anti-TNF-a treatment may be an important candidate for
treatment of asthma.
The fact that the alveolar macrophage mediated TNF-a
production is crucial for the development of allergic asthma like
features was supported by results from alveolar macrophage-
depletion using Cl2MDP-containing liposomes. Intranasal treat-
ment with Cl2MDP-containing liposomes [53,54] can selectively
deplete alveolar macrophages, whereas macrophages in the
interstitial zone and other monocytes were not affected [16,22].
Following the alveolar macrophage depletion, physiological
aggravation of the lung tissue in the GCE-asthma model mice
was improved, and TNF-a-producing cells were reduced in the
area. Our results are consistent with the previous reports showing
that alveolar macrophages are a major source of TNF-a in an
allergic asthma model [4,18,49]. TNF-a also can be produced by
endotoxin, but in this study we used endotoxin depleted GCE
which contain less than 0.01 EU/mL.
Our results suggest that the serine protease activity in GCE
induces TNF-a production by macrophages via the PAR-2
pathway. Upon intranasal administration of GCE intomice, allergic
asthma-like features developed as a result of alveolar macrophage
activation and TNF-a production in the lung tissue. This study,
however, does not provide a specific mechanism for PAR-2
activation in the GCE-induced asthma model, and the precise
mechanisms by which serine protease of GCE mediates allergic
airway inflammation via macrophages remain to be elucidated.
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Figure S1 PAR-2 internalization following activation
with GCE and/or aprotinin in MH-S cells. Cell-surface
expression of the PAR-2 is visualized by confocal imaging of cell-
surface staining. All data are representative of three independent
experiments.
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Figure S2 PAR-2 internalization following activation
with GCE and/or aprotinin in RAW264.7 cells. Cell-
surface expression of the PAR-2 is visualized by confocal imaging
of cell-surface staining. All data are representative of three
independent experiments.
(DOC)
Figure S3 GCE induces TNF-a production in RAW264.7
cells. (a) TNF-a production in RAW264.7 cells incubated with
GCE, GCE+PMB, or GCE+aprotinin. (b) Relative MFI ratio in
‘‘a’’ panel. (c) TNF-a secretion in the culture supernatant of ‘‘a’’
panel. * indicates statistical significance between ‘‘Control’’ and
‘‘GCE’’ (n = 3, p,0.05). # indicates statistical significance between
‘‘GCE’’ and ‘‘GCE+Aprotinin’’ (n = 3, p,0.05). All data are
representative of three independent experiments.
(DOC)
Figure S4 GCE induces TNF-a production in lung tissue
of mice. (a) Scheme for a long-term GCE exposure model. (b)
TNF-a expression in the macrophages of the lung tissue. All data
are representative of three independent experiments.
(DOC)
Figure S5 Intracellular cytokines expression in a long-
term GCE exposure model. (a) Intracellular expressions of
IFN-c, IL-5 and IL-17 from CD4+ T cells in the lung tissue of the
long-term GCE exposure model. (b) Cytokine+ T cells in ‘‘a’’
panel. (c) IL-10 and IL-17 production in the lung homogenate of
the long-term GCE exposure model. * indicates statistical
significance between ‘‘Sham’’ and ‘‘GCE’’ (n = 5, p,0.05).
(DOC)
Figure S6 Therapeutic effect of TNF-a blockade in a
short-term GCE exposure model. (a) AHR and (b) BAL cell
count. * indicates statistical significance between ‘‘Sham’’ and
‘‘GCE’’ (n = 5, p,0.05). # indicates statistical significance between
‘‘GCE’’ and ‘‘a-TNF’’ (n = 5, p,0.05). RL, pulmonary resistance;
Mac, macrophage; Lym, lymphocyte; Eos, eosinophil; Neu, neutro-
phil.
(DOC)
Figure S7 Quantitative analysis of (a) interstitial mac-
rophage and (b) dendritic cell population from GCE-
induced asthma model. All data are representative of three
independent experiments. (n = 5, p,0.05) IMs, interstitial macro-
phages; DCs, dendritic cells.
(DOC)
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